The DOI matches its Crossref record; 237 of the 237 references it cites were found in a registry or an index.
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Open accessAbstract
Fungal infections are a major contributor to infectious disease-related deaths across the globe. Candida species are among the most common causes of invasive mycotic disease, with Candida albicans reigning as the leading cause of invasive candidiasis. Given that fungi are eukaryotes like their human host, the number of unique molecular targets that can be exploited for antifungal development remains limited. Currently, there are only three major classes of drugs approved for the treatment of invasive mycoses, and the efficacy of these agents is compromised by the development of drug resistance in pathogen populations. Notably, the emergence of additional drug-resistant species, such as Candida auris and Candida glabrata, further threatens the limited armamentarium of antifungals available to treat these serious infections. Here, we describe our current arsenal of antifungals and elaborate on the resistance mechanisms Candida species possess that render them recalcitrant to therapeutic intervention. Finally, we highlight some of the most promising therapeutic strategies that may help combat antifungal resistance, including combination therapy, targeting fungal-virulence traits, and modulating host immunity. Overall, a thorough understanding of the mechanistic principles governing antifungal drug resistance is fundamental for the development of novel therapeutics to combat current and emerging fungal threats.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, large-scale genomic alterations, including aneuploidy, loss-of-heterozygosity (LOH), and chromosomal rearrangements, can affect the expression of drug targets, efflux pumps, and other resistance factors (7).”
From Potential role of lysine acetylation in the stepwise adaptation of Candida albicans to fluconazole (2025) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“These mutations lead to either the overexpression of the enzyme itself (14) or alterations in its activity that can lower fluconazole’s binding strength, leading to reduced drug effectiveness (15).”
From Candida albicans enhances iron uptake to maintain fluconazole resistance (2025) · cites this paper as [15]
In the citing paper
“the only new class of antifungal drugs developed in decades, the echinocandins, displays negligible antifungal activity against Cryptococcus spp.”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [2]
In the citing paper
“Treatment options for invasive cryptococcal infection are limited, given that Cryptococcus spp. are intrinsically resistant to echinocandins and that they employ an arsenal of defences that enable resistance to azoles2,8.”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [2]
In the citing paper
“the polyene amphotericin B has been the primary treatment for cryptococcal infection for more than half a century, despite the fact that it causes substantial toxicity and that its availability is limited by economic and logistical constraints2,4”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [2]
In the citing paper
“current antifungal drug treatments for invasive fungal infections are limited to polyenes, azoles and echinocandins2”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [2]
In the citing paper
“Combination therapy has the potential to confer enhanced efficacy and fungal selectivity while reducing vulnerability to the evolution of resistance2.”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lead- and drug-like compounds: the rule-of-five revolution
Lipinski, C. A. (2004) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2004.11.007 · Cited by 6,455
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
The Genetic Landscape of a Cell
Costanzo, M., Baryshnikova, A., Bellay, J., Kim, Y., Spear, E. D., Sevier, C. S., Ding, H., Koh, J. L. Y., Toufighi, K., Mostafavi, S., et al. (2010) · Science · doi:10.1126/science.1180823 · Cited by 2,162
Candida albicans pathogenicity mechanisms
Mayer, F. L., Wilson, D., & Hube, B. (2013) · Virulence · doi:10.4161/viru.22913 · Cited by 1,848
HSP90 at the hub of protein homeostasis: emerging mechanistic insights
Taipale, M., Jarosz, D. F., & Lindquist, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2918 · Cited by 1,818
Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662
Worldwide emergence of resistance to antifungal drugs challenges human health and food security
Fisher, M. C., Hawkins, N. J., Sanglard, D., & Gurr, S. J. (2018) · Science · doi:10.1126/science.aap7999 · Cited by 1,555
Research works printed but not linked: 1
- Besterman, J.; Nguyen, D. T.; Ste-Croix, H. MGCD290, an Oral Fungal Hos2 Inhibitor, Enhances the Antifungal Properties of Fluconazole Following Multiple-or Single-Dose Oral Administration in Pre-and Post-Infection Settings. In Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) ; MethylGene, Inc.: San Francisco, CA, 2012; Vol. Poster M-1711.
Cited by
Sorted by citations
Items 201–300 of 823
Antifungal Use and Resistance in a Lower–Middle-Income Country: The Case of Lebanon
Hassoun, N., Kassem, I. I., Hamzé, M., Tom, J. E., Papon, N., & Osman, M. (2023) · Antibiotics · doi:10.3390/antibiotics12091413 · Cited by 15
Silva, M. G. D. L., de Lima, L. F., Fonseca, V. J. A., da Silva, L. Y. S., Donelardy, A. C. C., de Almeida, R. S., Oliveira–Tintino, C. D. D. M., Martins, A. O. B. P. B., Ribeiro‐Filho, J., Morais‐Braga, M. F. B., et al. (2023) · Antibiotics · doi:10.3390/antibiotics12111565 · Cited by 16
Nanoformulations for dismantling fungal biofilms: The latest arsenals of antifungal therapy
Gupta, P., Meher, M. K., Tripathi, S., & Poluri, K. M. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101290 · Cited by 15
Yan, Z.-Z., Li, Q., Li, X., Wang, H., Zhao, D., Yu, H., Guo, M., Wang, Y., Wang, X., Xu, H., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00593 · Cited by 15
Synthesis and Photophysical Properties of Conjugated Fluorophores with N‐Heteroaromatic Rings
Bravo, N.-F., Cifuentes, C., Ríos, M., Pérez, L., & Portilla, J. (2025) · Asian Journal of Organic Chemistry · doi:10.1002/ajoc.202400742 · Cited by 15
Mathew, D., Thomas, B., M., S. N., Nair, S., & Radhakrishnan, E. K. (2025) · Advanced Powder Technology · doi:10.1016/j.apt.2025.104895 · Cited by 15
Advance and Designing Strategies in Polymeric Antifungal Agents Inspired by Membrane‐Active Peptides
Jiang, W., Wu, Y., Zhou, M., Song, G., & Liu, R. (2022) · Chemistry - A European Journal · doi:10.1002/chem.202202226 · Cited by 15
Robbins, N., & Cowen, L. E. (2022) · Current Opinion in Microbiology · doi:10.1016/j.mib.2022.102198 · Cited by 17
Self-citationLi, W., Feng, Y., Feng, Z., Wang, L., Whiteway, M., Lu, H., & Jiang, Y. (2024) · Antioxidants · doi:10.3390/antiox13060667 · Cited by 14
Yang, W., Zhang, Y., Teng, H. W., Liu, N., Sheng, C., & Guo, Y. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c00859 · Cited by 14
Siswina, T., Rustama, M. M., Sumiarsa, D., & Kurnia, D. (2023) · F1000Research · doi:10.12688/f1000research.125645.3 · Cited by 14
Khan, F., Irshad, R., Tanveer, N., Yaqoob, S., Razaullah, Raza, A., Ali, N., Saifullah, J., Hasan, K. A., Naz, S., et al. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107254 · Cited by 16
Pelliccia, S., Russomanno, P., Barone, S., Mateu, B., Alfano, A. I., Miranda, M., Coretti, L., Lembo, F., Piccolo, M., Irace, C., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01109 · Cited by 14
Ellagic Acid Potentiates the Inhibitory Effects of Fluconazole Against Candida albicans
Mendes, A. G. G., Campos, C. D. L., Filho, J. L. P., Pereira, A. P. A., Reis, G. S. A., Araújo, Á. W. M. D. S., Monteiro, P. D. M., Vidal, F. C. B., Monteiro, S. G., Figueiredo, I. F. D. S., et al. (2024) · Antibiotics · doi:10.3390/antibiotics13121174 · Cited by 14
Hassan, M. A., Noor, S., Park, J., Nabawy, A. M., Dedhiya, M., Patel, R., & Rotello, V. M. (2025) · Microorganisms · doi:10.3390/microorganisms13010127 · Cited by 14
The impact of phenotypic heterogeneity on fungal pathogenicity and drug resistance
Kozubowski, L., & Berman, J. G. (2025) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaf001 · Cited by 14
Frontiers in superbug management: innovating approaches to combat antimicrobial resistance
Chambial, P., Thakur, N., Bhukya, P. L., Anbazhagan, S., & Kumar, U. (2025) · Archives of Microbiology · doi:10.1007/s00203-025-04262-x · Cited by 15
Zoppo, M., Poma, N. V., Luca, M. D., Bottai, D., & Tavanti, A. (2021) · Journal of Fungi · doi:10.3390/jof7060459 · Cited by 14
Sasidharan, S., Nishanth, K. S., & Hareendran Nair, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.970688 · Cited by 15
Zhang, H., Xie, R., Zhang, H., Sun, R., Li, S., Xia, C., Li, Z., Zhang, L., Guo, Y., & Huang, J. (2023) · Poultry Science · doi:10.1016/j.psj.2023.102662 · Cited by 14
Akkuş‐Dağdeviren, Z. B., Saleh, A., Schöpf, C., Truszkowska, M., Bratschun-Khan, D., Fürst, A., Seybold, A., Offterdinger, M., Marx, F., & Bernkop‐Schnürch, A. (2023) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2023.05.051 · Cited by 14
Voronin, A. P., Vasilev, N. A., Surov, A. O., Churakov, A. V., & Perlovich, G. L. (2021) · CrystEngComm · doi:10.1039/d1ce01353j · Cited by 14
Unraveling Caspofungin Resistance in Cryptococcus neoformans
Papon, N., & Goldman, G. H. (2021) · mBio · doi:10.1128/mbio.00156-21 · Cited by 14
Allison, J. C., & Hyland, E. M. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1656723 · Cited by 13
Candida auris : host interactions, antifungal drug resistance, and diagnostics
Chowdhary, A., Lionakis, M. S., & Chauhan, N. (2025) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00187-22 · Cited by 17
Drug design strategies for the treatment azole-resistant candidiasis
Moghimi, S., Shafiei, M., & Foroumadi, A. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.2098949 · Cited by 13
Discovery of a new chemical scaffold for the treatment of superbug Candida auris infections
Tu, J., Zhu, T., Wang, Q., Yang, W., Huang, Y., Xu, D., Liu, N., & Sheng, C. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2208687 · Cited by 13
Autophagy Alters the Susceptibility of Candida albicans Biofilms to Antifungal Agents
Shen, J., Ma, M., Duan, W., Huang, Y., Shi, B., Wu, Q., & Wei, X. (2023) · Microorganisms · doi:10.3390/microorganisms11082015 · Cited by 13
Elgammal, Y., Salama, E. A., & Seleem, M. N. (2023) · Medical Mycology · doi:10.1093/mmy/myad081 · Cited by 13
Miguel, R. D. A., Hirata, A. S., Salata, G. C., Apolinário, A. C., Barroso, V. D. M., Ishida, K., Clair, J. J. L., Fenical, W., Martins, T. S., Costa-Lotufo, L. V., et al. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106635 · Cited by 13
Qian, W., Lu, J., Gao, C., Liu, Q., Li, Y., Zeng, Q., Zhang, J., Wang, T., & Chen, S. (2024) · Microbial Cell Factories · doi:10.1186/s12934-024-02369-2 · Cited by 13
Interdisciplinary approaches for the discovery of novel antifungals
Yiu, B., Robbins, N., & Cowen, L. E. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.04.018 · Cited by 14
Self-citationSecondary Metabolites from Marine-Derived Fungus Penicillium rubens BTBU20213035
Xu, X., Dong, Y., Yang, J., Wang, L., Ma, L., Song, F., & Ma, X. (2024) · Journal of Fungi · doi:10.3390/jof10060424 · Cited by 13
Yu, T. Y., Hou, J., Hafeez, F., Ge, P., Zou, A., Fu, Y., Zhang, J., & Xianyu, Y. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102486 · Cited by 13
Fungal Infections, Treatment and Antifungal Resistance: The Sub-Saharan African Context
Boakye-Yiadom, E., Odoom, A., Osman, A.-H., Ntim, O. K., Kotey, F. C. N., Ocansey, B. K., & Donkor, E. S. (2024) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361241297525 · Cited by 13
Stress contingent changes in Hog1 pathway architecture and regulation in Candida albicans
Day, A. M., Cao, M., Dantas, A. D. S., Ianieva, O., Herrero-de-Dios, C. M., Brown, A. J. P., & Quinn, J. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012314 · Cited by 13
“Illuminated Glycoporphyrins”: A photodynamic approach for Candida albicans inactivation
Palacios, Y. B., Simonetti, S. O., Chavez, C. H., Álvarez, M. G., Cordero, P. V., Cuello, E. A., López, E. J. G., Larghi, E. L., Agazzi, M. L., Durantini, E. N., et al. (2025) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2025.113105 · Cited by 13
Genomic Approaches to Antifungal Drug Target Identification and Validation
Robbins, N., & Cowen, L. E. (2022) · Annual Review of Microbiology · doi:10.1146/annurev-micro-041020-094524 · Cited by 15
Self-citationWang, X., Liu, P., Jiang, Y., Han, B., & Yan, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.992275 · Cited by 13
Polyphyllin I Effects Candida albicans via Inhibition of Virulence Factors
Sun, A.-M., Wang, Y.-X., Hu, G.-X., Li, L., & Wang, R.-R. (2023) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2023/5645500 · Cited by 13
Al-Enazi, N. M., Alsamhary, K. I., & Ameén, F. (2023) · Environmental Research · doi:10.1016/j.envres.2023.115599 · Cited by 13
Combating Antimicrobial Resistance in the Post-Genomic Era: Rapid Antibiotic Discovery
Yang, Y., Kessler, M. G. C., Marchán-Rivadeneira, M. R., & Han, Y. (2023) · Molecules · doi:10.3390/molecules28104183 · Cited by 13
Soni, A., Kumar, P., Tomar, V., Joshi, R. K., & Nemiwal, M. (2023) · Synthetic Communications · doi:10.1080/00397911.2023.2226271 · Cited by 13
Lee, J., Park, S., Kim, Y.-M., Guk, T., Lee, M.-Y., Park, S., Lee, M. Y., & Jang, M.-K. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081602 · Cited by 12
Mechanism of action and synergistic effect of Eugenia uniflora extract in Candida spp.
de Souza, L. B. F. C., Bento, A. D. O., Lourenço, E. M. G., Ferreira, M. R. A., de Oliveira, W. N., Soares, L. A. L., Barbosa, E. G., Rocha, H. A. O., & Chaves, G. M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0303878 · Cited by 12
Augello, S., Cameli, V., Montanari, A., Tacconi, S., Uccelletti, D., Dini, L., & Schifano, E. (2024) · Biomolecules · doi:10.3390/biom14111472 · Cited by 12
Voriconazole: a review of adjustment programs guided by therapeutic drug monitoring
Jiang, L., & Lin, Z. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1439586 · Cited by 12
Tijani, N. A., Hokello, J. F., Eilu, E., Akinola, S. A., Afolabi, A. O., Ntulume, I., & Adebayo, I. A. (2025) · Current Research in Biotechnology · doi:10.1016/j.crbiot.2025.100279 · Cited by 12
Zhang, W., Zhang, H., Gao, Y., Lei, J., & Suo, C. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1596688 · Cited by 14
Zhang, J., Gong, H., Liao, M., Li, Z., Schweins, R., Penny, J. I., & Lu, J. R. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.09.170 · Cited by 12
Kasabe, U., Kale, K. B., Rode, N. R., Shelar, A. V., Patil, R., Mhaske, P. C., & Chaskar, M. G. (2021) · New Journal of Chemistry · doi:10.1039/d1nj04168a · Cited by 12
The TAC1 Gene in Candida albicans : Structure, Function, and Role in Azole Resistance: A Mini-Review
Mahdizade, A. H., Hoseinnejad, A., Ghazanfari, M., Boozhmehrani, M. J., Bahreiny, S. S., Abastabar, M., Galbo, R., Giuffrè, L., Haghani, I., & Romeo, O. (2024) · Microbial Drug Resistance · doi:10.1089/mdr.2023.0334 · Cited by 12
Application of Reactive Oxygen Species in Dental Treatment
Komine, C., Uchibori, S., Tsudukibashi, O., & Tsujimoto, Y. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091531 · Cited by 12
Lipid Transport by Candida albicans Dnf2 Is Required for Hyphal Growth and Virulence
Jain, B. K., Wagner, A. S., Reynolds, T. B., & Graham, T. R. (2022) · Infection and Immunity · doi:10.1128/iai.00416-22 · Cited by 11
Naskar, S., Prajapati, A., & Kaur, R. (2025) · FEMS Yeast Research · doi:10.1093/femsyr/foaf025 · Cited by 14
Combating increased antifungal drug resistance in Cryptococcus, what should we do in the future?
Deng, H., Song, J., Huang, Y., Yang, C., Zang, X., Zhou, Y., Li, H., Dai, B., & Xue, X. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023011 · Cited by 12
Shao, H., Zhang, X., Yang, L., Gao, Y., Wang, Y., Shao, X., & Dai, L. (2024) · International Microbiology · doi:10.1007/s10123-024-00481-2 · Cited by 11
Evaluation of antifungal activity of visible light-activated doped TiO2 nanoparticles
Lozano‐Rosas, R., Ramos-Garcia, R., Salazar-Morales, M. F., Robles-Águila, M. J., & Mazzocco, T. S. (2024) · Photochemical & Photobiological Sciences · doi:10.1007/s43630-024-00557-y · Cited by 12
Silva, N. B. S., Menezes, R. D. P., Gonçalves, D. S., Santiago, M. B., Conejo, N. C., Souza, S. L., Santos, A. L. O., Silva, R. S., Ramos, S. B., Ferro, E. A. V., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-61179-z · Cited by 11
Jia, S., Huang, S., Jimo, R., Axi, Y., Lu, Y., Kong, Z., Ma, J., Li, H., Luo, X., Qu, Y., et al. (2024) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2024.122255 · Cited by 11
Kulig, K., Rąpała‐Kozik, M., & Karkowska‐Kuleta, J. (2024) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2024.100255 · Cited by 11
From Cas proteins to cutting-edge biosensors: A new era in clinical pathogen diagnostics
Yang, P., Zeng, J., Li, L., Ma, R., Peng, J., Zhou, W., Fu, W., Wu, Y., & Zhang, Y. (2025) · Journal of Infection · doi:10.1016/j.jinf.2025.106526 · Cited by 11
Mu, L., Xie, K., Chen, R., Cao, J., Yang, S., & Huang, X. (2025) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-025-04508-2 · Cited by 13
Feng, F., Li, J., Zhang, Z., Fu, J., Zhang, Y., & Gu, Q. (2021) · Chemical Research in Chinese Universities · doi:10.1007/s40242-021-0009-x · Cited by 11
Siswina, T., Rustama, M. M., Sumiarsa, D., & Kurnia, D. (2022) · F1000Research · doi:10.12688/f1000research.125645.1 · Cited by 11
Yadav, M., Kumar, A., Lal, K., Singh, M. B., & Kumari, K. (2023) · Research on Chemical Intermediates · doi:10.1007/s11164-022-04948-7 · Cited by 11
Unearth the ultrapotent intrinsic fungicidal efficacy of the surface-piercing CuFeSe2-PVP nano-blade
Wang, M., Zhou, Y., & Wang, Z. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.142603 · Cited by 11
McKenna, J. A., Garcia‐Ceron, D., Bleackley, M. R., Yu, L., Bulone, V., & Anderson, M. A. (2023) · Journal of Extracellular Biology · doi:10.1002/jex2.82 · Cited by 11
King, W. R., Singer, J. R., Warman, M., Wilson, D., Hube, B., Lager, I., & Patton, J. L. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105543 · Cited by 12
Izadi, A., Paknia, F., Roostaee, M., Mousavi, S. A. A., & Barani, M. (2024) · Nanotechnology · doi:10.1088/1361-6528/ad4bed · Cited by 11
Husain, F., Yadav, A., Sah, S. K., Hayes, J. J., & Rustchenko, E. (2022) · Microorganisms · doi:10.3390/microorganisms11010023 · Cited by 10
Wu, Y., Zou, Y., Dai, Y., Lu, H., Zhang, W., Chang, W., Wang, Y., Nie, Z., Wang, Y., & Jiang, X. (2025) · PLOS Pathogens · doi:10.1371/journal.ppat.1013220 · Cited by 10
Harley, B. K., Neglo, D., Aggrey, M. O., Quagraine, A. M., Orman, E., Jato, J., Mireku-Gyimah, N. A., Amengor, C. D. K., & Fleischer, T. C. (2022) · BioMed Research International · doi:10.1155/2022/4261741 · Cited by 11
Park, J., Kim, H., Kang, H., Choi, M., & Park, Y. (2022) · Journal of Fungi · doi:10.3390/jof8090901 · Cited by 10
Urbanek, A. K., Łapińska, Z., Derkacz, D., & Krasowska, A. (2022) · Pathogens · doi:10.3390/pathogens11111289 · Cited by 11
Liu, Z., Li, Y., Wei, D., Wang, J., Qiao, C., Li, G., Zhang, G., & Luo, Y. (2023) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00490 · Cited by 10
TheiaEuk: a species-agnostic bioinformatics workflow for fungal genomic characterization
Ambrosio, F. J., Scribner, M. R., Wright, S. M., Otieno, J. R., Doughty, E. L., Gorzalski, A. J., Siao, D. D., Killian, S., Hua, C. N., Schneider, E., et al. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1198213 · Cited by 11
Zheng, D., Yue, D., Shen, J., Li, D., Song, Z., Huang, Y., Yong, J., & Li, Y. (2023) · Journal of Applied Microbiology · doi:10.1093/jambio/lxad276 · Cited by 10
Rovetta, S. D. M., Borges, A. C., Filho, M. D. O., Nishime, T. M. C., Hein, L. R. D. O., Kostov, K. G., & Koga‐Ito, C. Y. (2023) · Molecules · doi:10.3390/molecules28237919 · Cited by 11
Exploring the Potential of Farnesol as a Novel Antifungal Drug and Related Challenges
Dongming, Z., Yang, L., Bai, Y., Yong, J., & Li, Y. (2024) · Current Infectious Disease Reports · doi:10.1007/s11908-024-00839-7 · Cited by 10
Wang, J., Shen, J., Chen, D., Liao, B., Chen, X., Zong, Y., Wei, Y., Shi, Y., Liu, Y., Gou, L., et al. (2024) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-024-13063-z · Cited by 11
Optimization of the antifungal properties of the bacterial peptide EntV by variant analysis
Guha, S., Cristy, S. A., Cesare, G. B. D., Cruz, M. R., Lorenz, M. C., & Garsin, D. A. (2024) · mBio · doi:10.1128/mbio.00570-24 · Cited by 10
Anti-Candida albicans effect and mechanism of Pachysandra axillaris Franch.
Duan, Y., Wang, Z., Mei, L.-N., Shen, J.-S., He, X.-C., & Luo, X. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.119284 · Cited by 10
Antifungal effects of thiosemicarbazone-chalcones on Aspergillus, Candida and Sporothrix strains
Felippe, W. Q., Barbosa, I. R., Oliveira, A. A. P., da Costa, G. L., & Echevarrı́a, A. (2025) · Archives of Microbiology · doi:10.1007/s00203-024-04229-4 · Cited by 10
Effect of Defined Block Sequence Terpolymers on Antifungal Activity and Biocompatibility
Gmedhin, H., Schaefer, S., Corrigan, N. A., Wu, P., Gu, Z., Lenardon, M. D., & Boyer, C. A. (2025) · Macromolecular Bioscience · doi:10.1002/mabi.202400429 · Cited by 10
Kılbaş, İ., Kilbaş, E. P. K., Horhat, F. G., & Çiftçi, İ. H. (2025) · Journal of Fungi · doi:10.3390/jof11080603 · Cited by 10
Cedeño-Pinargote, A. C., Jara-Medina, N. R., Pineda-Cabrera, C. C., Cueva, D. F., Erazo-Garcia, M. P., Tejera, E., & Machado, A. (2025) · Journal of Fungi · doi:10.3390/jof11090620 · Cited by 10
Li, X., Sholeh, M., Moghadam, M. A., Ostadrahimi, M., & Hosseini, S. S. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-12653-8 · Cited by 12
Luna-Tapia, A., Parker, J. E., Kelly, S. L., & Palmer, G. E. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01044-21 · Cited by 11
Zhang, Q., Zhang, M., Wang, Y., Tingting, Z., Roujuan, W., Shuhong, W., Du, Y., Ruirui, Y., Peng, Y., Yifan, S., et al. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c01417 · Cited by 10
Gong, Y., Yin, S., Sun, S., & Li, M. (2022) · Future Microbiology · doi:10.2217/fmb-2021-0203 · Cited by 10
Madanchi, H., Rahmati, S., Doaei, Y., Sardari, S., Maleki, M. S. M., Rostamian, M., Kiasari, R. E., Mousavi, S. J. S., Ghods, E., & Ardekanian, M. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105866 · Cited by 10
Nasiri, S., Mahmoudvand, H., Shakibaei, M. R., Mousavi, S. A. H., & Sepahvand, A. (2022) · Journal of Herbmed Pharmacology · doi:10.34172/jhp.2022.62 · Cited by 10
Improving Drug Delivery on Candida Albicans Using Geraniol Nanoemulsion
Pontes, C. S., de Carvalho, G. G., Leite, A. R. P., Chorilli, M., & Spolidório, D. M. P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102475 · Cited by 10
Mucoadhesive delivery systems for oral candidiasis treatment: A systematic review and meta‐analysis
Sugio, C. Y. C., Garcia, A. A. M. N., Kitamoto, K. A. D. A., Santiago, J. F., Soares, S., Porto, V. C., Urban, V. M., Ferrari, P. C., Fernandes, M. H., & Neppelenbroek, K. H. (2024) · Oral Diseases · doi:10.1111/odi.14928 · Cited by 10
Lanze, C. E., & Konopka, J. B. (2024) · Molecular Biology of the Cell · doi:10.1091/mbc.e23-08-0324 · Cited by 10
Fungal Lysine Deacetylases in Virulence, Resistance, and Production of Small Bioactive Compounds
Bauer, I., & Graessle, S. (2021) · Genes · doi:10.3390/genes12101470 · Cited by 11
Jaiswal, N., & Kumar, A. (2024) · Molecular Biotechnology · doi:10.1007/s12033-023-01017-1 · Cited by 9
Pharmaceutical salts of azole anti-fungal drugs: physicochemical behaviour and activity studies
Qadri, H., Malik, A. A., Ahangar, A. A., Mir, M. A., Dar, A. A., & Shah, A. H. (2024) · RSC Pharmaceutics · doi:10.1039/d4pm00003j · Cited by 9
Chao, W., Qiu, L., Gao, L., Feng, J., Liu, Y., Yan, L., Jiang, Y., & Lv, Q. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00069 · Cited by 9
Metadata
- Authors
- Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Cowen, Leah E.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-05-22
- Volume
- 121
- Issue
- 6
- Pages
- 3390-3411
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- PMC
- PMC8519031
- OpenAlex
- W3026958586
- Cited by
- 801
- References
- 237
- Citations by year
- 2026: 109 · 2025: 192 · 2024: 168 · 2023: 133 · 2022: 132 · 2021: 63 · 2020: 4
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Chemical Reviews (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Canadian Institutes of Health Research (FDN-154288)
- National Institute of Allergy and Infectious Diseases (1R01AI127375-01)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- antifungal resistance, Candida albicans, Candida auris, Candida glabrata, invasive candidiasis, antifungal agents, molecular mechanisms of resistance, combination antifungal therapy, fungal virulence factors, emerging fungal pathogens
- MeSH terms
- Drug Development, Animals, Antifungal Agents, Candida, Candida albicans, Drug Therapy, Combination, Humans, Mycoses, Virulence, Molecular Structure, Signal Transduction, Drug Resistance, Fungal, Candida glabrata
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review